In this Issue:
Ribavirin for chronic HEV in solid-organ transplantation
IL28B polymorphisms and spontaneous HBsAg seroclearance
BCAA supplementation reduces HCC incidence
Genetic factors in fibrosis progression
Exploring viral persistence in HCV
Twice-daily telaprevir in chronic HCV
Daclatasvir + asunaprevir in HCV GT1 null responders
Understanding the efficacy of pegIFN-α
HBV immune escape mutants
On-treatment AFP for HCC surveillance?
Please login below to download this issue (PDF)